Anebulo Pharmaceuticals (ANEB) Free Cash Flow (2020 - 2025)
Anebulo Pharmaceuticals' Free Cash Flow came in at -$1.31 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$1.41 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Free Cash Flow (2020 - 2025) Analysis & Trends
Over the trailing twelve months to Dec 31, 2025, Anebulo Pharmaceuticals reported Free Cash Flow of -$5.84 million; for FY2025 (ended Jun 30, 2025), it came in at -$6.35 million.
- Going back by fiscal year, Free Cash Flow was -$8.09 million in FY2024, -$9.68 million in FY2023, -$5.44 million in FY2022 and -$4.87 million in FY2021.
- The five-year range for quarterly Free Cash Flow is -$3.5 million (fiscal Q4 2021) to -$777,902 (fiscal Q1 2022).
- Business Quant data shows ANEB's Free Cash Flow at -$1.27 million (Q1 2026), -$1.65 million (Q4 2025) and -$1.6 million (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 6.36 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 5.56 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 1.01 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Anebulo Pharmaceuticals | 11.91 Mn | -32.39 Mn | - | -1.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | -2.05 Mn |
| Mar 31, 2024 | -1.50 Mn |
| Dec 31, 2023 | -1.81 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -2.19 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -2.03 Mn |
| Jun 30, 2022 | -2.00 Mn |
| Mar 31, 2022 | -1.46 Mn |
| Dec 31, 2021 | -1.20 Mn |
| Sep 30, 2021 | -777,902.00 |
| Jun 30, 2021 | -3.50 Mn |
| Mar 31, 2021 | -828,904.00 |
API Access
Anebulo Pharmaceuticals Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();